Ronald R Tuttle

This inventor holds 22 USPTO granted patents. Top assignees: Trega Biosciences, Inc., Gensia Pharmaceuticals, Inc., Eli Lilly and Company. Active years: 1976-2003.

USPTO Granted Patents = 22

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 13

Forward Citations = 592(Granted Patents)

Location History:

Indianapolis, IN (US) (1976)
Oceanside, CA (US) (1995)
Escondido, CA (US) (1989 - 2003)

Company Filing History:

7 out of 22

Trega Biosciences, Inc.

patents

5 out of 14

Gensia Pharmaceuticals, Inc.

patents

3 out of 4,508

Eli Lilly and Company

patents

4. 2 out of 6

Houghten Pharmaceuticals, Inc.

Baker Cumins Dermatologicals, Inc.

The University of Texas System

patents

Years Active: 1976-2003

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6534503 - Melanocortin receptor-3 ligands to treat sexual dysfunction (2003-03-18),

2. 6284735 - HP-3228 and related peptides to treat sexual dysfunction (2001-09-04),

3. 6245738 - Cytokine restraining agents (2001-06-12),

4. 5965536 - Methods of inhibiting CXC intercrine molecules (1999-10-12),

5. 5888978 - Method for reducing the severity of gastro-intestinal damage (1999-03-30),

6. 5888969 - Use of cytokine restraining agents to treat inflammatory bowel disease (1999-03-30),

7. 5786332 - Cytokine restraining agents and methods of use in pathologies and (1998-07-28),

8. 5760001 - Cytokine restraining agents and methods of use in pathologies and (1998-06-02),

9. 5741774 - Use of a cytokine regulatory agent to treat rheumatoid arthritis (1998-04-21),

10. 5726156 - Cytokine regulatory agents and methods of use in pathologies and (1998-03-10),

11. 5658889 - Method and compounds for aica riboside delivery and for lowering blood (1997-08-19),

12. 5643967 - Growth promotion (1997-07-01),

13. 5597843 - Use of a substituted 1,3-benzodioxole to reduce a wasting condition (1997-01-28),

14. 5460605 - Diagnosis, evaluation and treatment of coronary artery disease by (1995-10-24),

15. 5420109 - Cytokine restraining agents (1995-05-30),

Title: Inventor Ronald R Tuttle: Pioneering Innovations in Escondido

Introduction: Ronald R Tuttle is a distinguished inventor based in Escondido, California, known for his groundbreaking contributions to various fields.

Latest Patents: Ronald R Tuttle holds several patents in the areas of technology and engineering, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, Ronald R Tuttle has established himself as a visionary inventor, with a keen focus on developing solutions that push the boundaries of traditional practices.

Collaborations: Throughout his career, Ronald R Tuttle has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: Ronald R Tuttle's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in Escondido, California, inspiring future generations to think outside the box and pursue their inventive dreams.